Multiple sclerosis (MS) is the most common neurological disease of young adults in the United States, with a prevalence estimated to be 400,000 and with annual medical expenses and lost productivity costs of approximately $9.5 billion. We hypothesize (Central Hypothesis) that microvascular abnormalities (a consequence of the perivenous inflammation known to occur in MS) are a final common pathway leading to injury of the central nervous system. This hypothesis is based upon preliminary data we have gathered and is supported by pathological evidence of such injury. Ensuing microvascular ischemic damage to axons/neurons interferes with normal iron homeostasis, resulting in accumulation of excess iron in the deep gray matter. Neurocognitive deficits and fatigue experienced by MS patients are consequences of oxidative injury by iron accretion in the basal ganglia and thalamus. To test this hypothesis, we propose four Specific Aims:
Specific Aim 1 defines baseline perfusion (cerebral blood flow;cerebral blood volume;mean transit time), magnetic resonance (MR) spectroscopy (N-acetyl aspartate), and quantitative MR metrics (diffusion tensor;diffusion kurtosis;magnetic field correlation;structural volume) at high-field (3 Tesla) in 30 early relapsing remitting MS patients and age/sex matched controls.
Specific Aim 2 measures baseline cognitive impairment and fatigue and associates these results with quantitative MR metrics of the deep gray matter.
Specific Aim 3 associates, over a 4 year duration, deep gray matter iron accumulation with both damage to these structures and progressive brain parenchymal loss.
Specific Aim 4 associates, over a 4 year duration, the decline in neurocognitive function and fatigue with deep gray matter injury. This research will provide new insights into the pathophysiology of Multiple Sclerosis and common morbidities (cognitive decline and fatigue) experienced by MS patients. It will result in more appropriate measures to detect and quantitate the effect of the disease and will provide a rationale for innovative treatment regimes.
|Kirov, Ivan I; Liu, Shu; Tal, Assaf et al. (2017) Proton MR spectroscopy of lesion evolution in multiple sclerosis: Steady-state metabolism and its relationship to conventional imaging. Hum Brain Mapp 38:4047-4063|
|Zhou, Yongxia (2016) Quantitative PET/MRI Evaluation and Application in Dementia. Jacobs J Med Diagn Med Imaging 1:|
|Marshall, Olga; Chawla, Sanjeev; Lu, Hanzhang et al. (2016) Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study. J Cereb Blood Flow Metab 36:2087-2095|
|Chawla, S; Kister, I; Wuerfel, J et al. (2016) Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI. AJNR Am J Neuroradiol 37:1223-30|
|Raz, Eytan; Branson, Brittany; Jensen, Jens H et al. (2015) Relationship between iron accumulation and white matter injury in multiple sclerosis: a case-control study. J Neurol 262:402-9|
|Bester, M; Jensen, J H; Babb, J S et al. (2015) Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis. Mult Scler 21:935-44|
|Jonkman, Laura E; Rosenthal, Diana M; Sormani, Maria Pia et al. (2015) Gray Matter Correlates of Cognitive Performance Differ between Relapsing-Remitting and Primary-Progressive Multiple Sclerosis. PLoS One 10:e0129380|
|Marshall, Olga; Uh, Jinsoo; Lurie, Daniel et al. (2015) The influence of mild carbon dioxide on brain functional homotopy using resting-state fMRI. Hum Brain Mapp 36:3912-21|
|Chawla, S; Ge, Y; Lu, H et al. (2015) Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge. AJNR Am J Neuroradiol 36:2055-61|
|Marshall, Olga; Lu, Hanzhang; Brisset, Jean-Christophe et al. (2014) Impaired cerebrovascular reactivity in multiple sclerosis. JAMA Neurol 71:1275-81|
Showing the most recent 10 out of 106 publications